期刊文献+

阿司匹林在颅内动脉瘤支架辅助栓塞术后的应用 被引量:11

Application of aspirin following stent-aiding embolism operation for cerebral aneurysm
下载PDF
导出
摘要 目的探讨阿司匹林在颅内动脉瘤支架辅助栓塞术后应用的时间和疗效。方法选择2005年1月-2008年6月我院48例颅内动脉瘤支架辅助栓塞术后患者,随机分为阿司匹林组和对照组,阿司匹林组给予阿司匹林(100mg,1次/d)口服,3个月、6个月后各行1次血常规及凝血检查;3个月后行DSA检查,评价动脉瘤形状及患者神经功能情况。结果3个月内,口服阿司匹林较未口服阿司匹林患者发生神经功能缺失明显减少,P<0.05;口服阿司匹林6个月的患者发生神经功能缺失情况与口服3个月组比较,P>0.05。口服阿司匹林患者血常规及凝血、动脉瘤形状无明显变化。结论颅内动脉瘤支架辅助栓塞术后口服阿司匹林3个月可达到防治患者神经功能缺失作用,不增加术后动脉瘤复发的发生危险或引起动脉瘤破裂。 Objective To investigate the application of aspirin being given after stent-alding embolism operation for cerebral aneurysm. Methods 48 patients with cerebral aneurysm after stent-aiding embolism operation were randomly divided into 2 groups. Treatment group was treated with aspirin (100 mg, once per day) , and the control group was given placebo. In the treatment group, the blood routine and blood clotting was examined after 3 months and 6 months respectively, DSA was examined after 3 months. Results Loss of neuro-function in patients of treatment group was lower than that of control group,P 〈0.05. In treatment group,there was no significant difference in variation of neuro-function between the patients treated for 3 months and 6 months, P 〉 0.05. Blood routine, blood clotting and the shape of aneurysm of treatment group bad no obvious change. Conclusion Aspirin has control effect on loss of neuro-function when used for 3 months after stent-aiding embolism operation for cerebral aneurysm, and it did not raise the recrudescence of aneurysm or disruption of aneurysm after operation.
出处 《实用药物与临床》 CAS 2009年第1期9-11,共3页 Practical Pharmacy and Clinical Remedies
关键词 阿司匹林 颅内动脉瘤 支架 栓塞 Aspirin Cerebral aneurysm Stent Embolism
  • 相关文献

参考文献8

  • 1HIgashiida RT, Smith W, Gress D, et al. htravaseular stent and endovascular coil placement for a ruptured fusiform aneurysm of the basilar artery, ease report and review of the literature[ J]. J Neurosurg, 1997,87:944-949.
  • 2马廉亭.脑血管疾病血管内治疗学及图谱[M].第2版.河南科学技术出版社,2003:214.
  • 3Brener SJ, Steinhubl SR, Berger PB, et al. Prolonged dual an tiplate-let thempy after percutaneous coronary intervention reduces ischemic events without affecting the need for repeat revascularization : insights from the CREDO trial [ J]. J Invasive Cardiol,2007,19 (7) : 287 - 290.
  • 4杨宝峰.药理学[M].第6版.北京:人民卫生出版社,2004.183.
  • 5Soga Y, Yokoi H, Kawasaki T, et al. Efficacy of cilostazol after endovascular therapy for femoropopliteal artery disease in patients with intermittent claudication [ J ]. J Am Coll Cardiol, 2009,53( 1 ) :48-53.
  • 6Saratzis A, Saratzis N, Melas N, et al. Pharmacotherapy before and after endovascular repair of abdominal aortic aneurysms [J]. Curt Vase Pharmacol,2008 ,6 (4) :240-249.
  • 7Mehm SR, Yusuf S, Peters RJ, et al. Effets of pretreatmentwith c10 pidogrel and aspirin folowed by long term therapy in patients undergoing percutaneous coronary intervention: the PCICURE study[ J]. Lancet,2001,358(9281 ) :527-533.
  • 8姚菁,郑治渊,黄芸,张维,谈中茹,陈阳,邱朝晖,朱华.老年患者在冠脉支架术后长期联合运用阿司匹林和氯吡格雷的安全性及有效性的临床观察[J].老年医学与保健,2007,13(4):234-236. 被引量:5

二级参考文献7

  • 1Mehta SR,Yusuf S,Peters RJ,et al.Effects of pretreatment with clopidogrel and aspirin followed by long term therapy in patients undergoing percutaneous coronary intervention:the PCICURE study.Lancet,2001,358(9281):527-533.
  • 2Sakatani H,Degawa T,Nakamura M,et al.Intracoronary surface changes after Palmaz Schatz stentim plantation:serial observations with coronary angioscopy.Am Heart J,1999,138:962-967.
  • 3Brmunwald E.Application of current guidelines to the management of unstahle angina and non ST elevation myocardial infarction.Circulation,2003,16(1):28-37.
  • 4Smith SC,Dove JT,Jacobs AK,et al.ACC/AHA guidelines for percutaneous coronary intervention:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1993 Guidelines for Percutaneous Transluminal Coronary Angioplasty).J Am Coll Cardiol,2001,37:2215-2239.
  • 5Geiger J,Brich J,Hong-Liedl P,et al.Specific impairment of human platelet P2Y (AC) ADP receptor-mediated signaling by the antiplatelet drug clopidogrel.Arterioscler Thromb Vasc Biol,1999,19(8):2007-2011.
  • 6周瑞海,高海青,奚斌,刘向群,朱媛媛,解敏.噻氯吡啶对冠心病患者血小板聚集及血浆纤维蛋白原水平的影响[J].中国临床药理学杂志,1999,15(2):86-88. 被引量:10
  • 7李玉杰,麦炜颐,曾群英,何清,刘莉莉.冠心病患者血小板聚集功能及噻氯匹啶作用的观察[J].中国病理生理杂志,2000,16(8):702-704. 被引量:8

共引文献26

同被引文献73

引证文献11

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部